Under his leadership, Duke has established Duke Translational Medicine Institute, Duke Global Health Institute, Duke-NUS Medical School in Singapore and Duke Institute of Health Innovation.
As one of the world’s most preeminent academic health leaders, Dr. Dzau advises governments, businesses and universities worldwide, serving on advisory councils and boards of directors. He is a Council member of the Institute of Medicine (IOM) of the National Academy of Science USA, a member of the Board of Directors of Singapore Health System, former member of the Advisory Board of Canadian Institute for Health Research, former member of the Advisory Council to Director of National Institute of Health (NIH), chair of the NIH Cardiovascular Disease Advisory Committee and past chair of the Association of Academic Health Centers.
In 2011, he led a partnership among Duke Medicine, World Economic Forum and McKinsey & Company to establish the International Partnership for Innovative Healthcare Delivery, and chairs its Board of Directors.
But while active in world medical circles, he has been cognizant of how health reform, particularly the Affordable Care Act, is transforming medicine in America.